{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T19:03:25Z","timestamp":1773169405475,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.ahj.2010.02.035","type":"journal-article","created":{"date-parts":[[2010,6,9]],"date-time":"2010-06-09T04:30:55Z","timestamp":1276057855000},"page":"1095-1101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["A multicenter, open-label study of vernakalant for the conversion of atrial fibrillation to sinus rhythm"],"prefix":"10.1016","volume":"159","clinical-trial-number":[{"clinical-trial-number":"nct00281554","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00989001","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Ian G.","family":"Stiell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan S.","family":"Roos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine M.","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garth","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2010.02.035_bib1","series-title":"Cardiac arrhythmias: a clinical approach","first-page":"3","article-title":"Epidemiology and costs of cardiac arrhythmias","author":"Freestone","year":"2003"},{"key":"10.1016\/j.ahj.2010.02.035_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijcard.2005.12.001","article-title":"Pharmacologic approaches to rhythm versus rate control in atrial fibrillation\u2014where are we now?","volume":"110","author":"Wyse","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2010.02.035_bib3","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2010.02.035_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijcard.2006.12.014","article-title":"Arrhythmic complications of electrical cardioversion: relationship to shock energy","volume":"123","author":"Gallagher","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2010.02.035_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2515\/therapie:2007009","article-title":"Incidence of early adverse events surrounding direct current cardioversion of persistent atrial fibrillation. A cohort study of practices","volume":"62","author":"Guedon-Moreau","year":"2007","journal-title":"Therapie"},{"key":"10.1016\/j.ahj.2010.02.035_bib6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.resuscitation.2004.01.017","article-title":"The incidence and severity of cutaneous burns following external DC cardioversion","volume":"61","author":"Ambler","year":"2004","journal-title":"Resuscitation"},{"key":"10.1016\/j.ahj.2010.02.035_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1067\/mhj.2003.112","article-title":"Outpatient cardioversion of atrial arrhythmias: efficacy, safety, and costs","volume":"145","author":"Botkin","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2010.02.035_bib8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/heart.87.6.535","article-title":"Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation","volume":"87","author":"Nichol","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2010.02.035_bib9","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJM199909163411201","article-title":"Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group","volume":"341","author":"Torp-Pedersen","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2010.02.035_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jacc.2004.03.047","article-title":"Safety and efficacy of intravenously administered tedisamil for rapid conversion of recent-onset atrial fibrillation or atrial flutter","volume":"44","author":"Hohnloser","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2010.02.035_bib11","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1540-8167.2005.50028.x","article-title":"The mechanism of atrial antiarrhythmic action of RSD1235","volume":"16","author":"Fedida","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ahj.2010.02.035_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/FJC.0b013e3180547553","article-title":"The effect of vernakalant (RSD1235), an investigational antiarrhythmic agent, on atrial electrophysiology in humans","volume":"50","author":"Dorian","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ahj.2010.02.035_bib13","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.jacc.2004.09.021","article-title":"A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation","volume":"44","author":"Roy","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2010.02.035_bib14","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1161\/CIRCULATIONAHA.107.723866","article-title":"Vernakalant hydrochloride for rapid conversion of atrial fibrillation. A phase 3, randomized, placebo-controlled trial","volume":"117","author":"Roy","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2010.02.035_bib15","first-page":"47","article-title":"Efficacy and tolerance of RSD1235 in the treatment of atrial fibrillation or atrial flutter: results of a phase III, randomized, placebo-controlled, multicenter trial","volume":"1-36","author":"Pratt","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2010.02.035_bib16","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1161\/circ.114.4.257","volume":"114","author":"Fuster","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2010.02.035_bib17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0735-1097(96)00121-0","article-title":"Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study","volume":"28","author":"Ellenbogen","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2010.02.035_bib18","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1161\/01.CIR.94.7.1613","article-title":"Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators","volume":"94","author":"Stambler","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2010.02.035_bib19","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0002-8703(98)70010-9","article-title":"Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation. Study Investigators","volume":"136","author":"Abi-Mansour","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2010.02.035_bib20","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/0735-1097(95)00595-1","article-title":"Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study","volume":"27","author":"Galve","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2010.02.035_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9149(92)91392-H","article-title":"Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension","volume":"70","author":"Capucci","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2010.02.035_bib22","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1111\/j.1540-8159.1998.tb01203.x","article-title":"Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols","volume":"21","author":"Boriani","year":"1998","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.ahj.2010.02.035_bib23","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1197\/j.aem.2007.07.016","article-title":"Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter","volume":"14","author":"Stiell","year":"2007","journal-title":"Acad Emerg Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870310002309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870310002309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:41:53Z","timestamp":1757569313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870310002309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0002870310002309"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2010.02.035","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multicenter, open-label study of vernakalant for the conversion of atrial fibrillation to sinus rhythm","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2010.02.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}